Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Duality Biologics completes $90 million Series B financing
Duality Biologics announced that it had completed a $90 million Series B financing led by Lilly Asia Ventures, with other funds participating. The proceeds are primarily intended to support preclinical research, clinical development and product licensing across the company’s pipeline.